Fabrice Carrat
Fabrice Carrat
Professor Public health, epidemiology, biostatistics, university paris 6
Verified email at
Cited by
Cited by
Time lines of infection and disease in human influenza: a review of volunteer challenge studies
F Carrat, E Vergu, NM Ferguson, M Lemaitre, S Cauchemez, S Leach, ...
American journal of epidemiology 167 (7), 775-785, 2008
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
L Beaugerie, N Brousse, AM Bouvier, JF Colombel, M Lémann, J Cosnes, ...
The Lancet 374 (9701), 1617-1625, 2009
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial
F Carrat, F Bani-Sadr, S Pol, E Rosenthal, F Lunel-Fabiani, A Benzekri, ...
Jama 292 (23), 2839-2848, 2004
Influenza vaccine: the challenge of antigenic drift
F Carrat, A Flahault
Vaccine 25 (39-40), 6852-6862, 2007
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis
D Saadoun, M Rosenzwajg, F Joly, A Six, F Carrat, V Thibault, D Sene, ...
New England Journal of Medicine 365 (22), 2067-2077, 2011
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890
C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ...
Journal of hepatology 59 (3), 434-441, 2013
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease
L Peyrin–Biroulet, K Khosrotehrani, F Carrat, AM Bouvier, JB Chevaux, ...
Gastroenterology 141 (5), 1621-1628. e5, 2011
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
C Corpechot, F Carrat, A Bahr, Y Chrétien, RE Poupon, R Poupon
Gastroenterology 128 (2), 297-303, 2005
Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases
J Kirchgesner, M Lemaitre, F Carrat, M Zureik, F Carbonnel, R Dray-Spira
Gastroenterology 155 (2), 337-346. e10, 2018
Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease
M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat, M Zureik, F Carbonnel, ...
Jama 318 (17), 1679-1686, 2017
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
F Carrat, H Fontaine, C Dorival, M Simony, A Diallo, C Hezode, ...
The Lancet 393 (10179), 1453-1464, 2019
A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data
S Cauchemez, F Carrat, C Viboud, AJ Valleron, PY Boëlle
Statistics in medicine 23 (22), 3469-3487, 2004
Liver biopsy: the best, not the gold standard
P Bedossa, F Carrat
Journal of hepatology 50 (1), 1-3, 2009
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease
L Beaugerie, M Svrcek, P Seksik, AM Bouvier, T Simon, M Allez, H Brixi, ...
Gastroenterology 145 (1), 166-175. e8, 2013
Risk factors of influenza transmission in households
C Viboud, PY Boëlle, S Cauchemez, A Lavenu, AJ Valleron, A Flahault, ...
British Journal of General Practice 54 (506), 684-689, 2004
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
C Corpechot, F Carrat, AM Bonnand, RE Poupon, R Poupon
Hepatology 32 (6), 1196-1199, 2000
Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis
C Corpechot, F Carrat, A Poujol‐Robert, F Gaouar, D Wendum, ...
Hepatology 56 (1), 198-208, 2012
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis
C Hézode, H Fontaine, C Dorival, F Zoulim, D Larrey, V Canva, ...
Gastroenterology 147 (1), 132-142. e4, 2014
Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster‐randomized trial
M Lemaitre, T Meret, M Rothan‐Tondeur, J Belmin, JL Lejonc, L Luquel, ...
Journal of the American Geriatrics Society 57 (9), 1580-1586, 2009
Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
MB Zeisel, J Lucifora, WS Mason, C Sureau, J Beck, M Levrero, M Kann, ...
Gut 64 (8), 1314-1326, 2015
The system can't perform the operation now. Try again later.
Articles 1–20